Clinical Trial Update: Paricalcitol Improves Anemia of Inflammation [Phase 4]

View source ↗

Summary

Phase 4 trial results indicate that paricalcitol may improve anemia of inflammation. The update suggests potential therapeutic benefit in inflammatory anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Disease
• Anemia of Inflammation

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Hospital Son Espases | Conditions: Anemia | Phase 4 | Status: TERMINATED